Medicago's P2P Acquisition

Medicago raised a round of funding on September 18, 2013. Investors include Mitsubishi Tanabe Pharma.

Medicago is a clinical-stage biopharmaceutical company developing novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The Company is committed to providi…

Articles about Medicago's P2P Acquisition: